Table 1.
Virus isolation from BAL fluid
| Vaccine | RM no. | BAL day 1 | BAL day 3 |
|---|---|---|---|
| ChAd-SARS-COV-2-S | 1 | − | − |
| 2 | − | − | |
| 3 | − | − | |
| 4 | − | − | |
| 5 | − | − | |
| 6 | + | − | |
| ChAd-Control | 7 | + | − |
| 8 | ++ | − | |
| 9 | +++ | ++ | |
| 10 | ++ | − | |
| 11 | + | − | |
| 12 | + | − |
−, negative; +, <102 TCID50/mL; ++, 102–104 TCID50/mL; +++, 105 TCID50/mL; BAL, bronchoalveolar lavage; RM, rhesus macaque; and TCID50, tissue culture infectious dose 50.